Management of growth retardation in the young patient with Crohn's disease

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 1, 2002, Pages 1-7

  Ballinger, Anne ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Corticosteroids; Growth; Inflammation; Nutrition; Paediatric Crohn's disease

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; POLYMER; PREDNISOLONE;

ACUTE PANCREATITIS; ADOLESCENT; ANTIINFLAMMATORY ACTIVITY; BODY HEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE EXACERBATION; DRUG EFFECT; DRUG FORMULATION; DRUG HYPERSENSITIVITY; ELEMENTAL DIET; ENTERIC FEEDING; FEVER; GROWTH RATE; GROWTH RETARDATION; GROWTH STIMULATION; HEALING; HUMAN; INFLAMMATION; MALNUTRITION; NEUTROPENIA; NUTRITIONAL DEFICIENCY; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; REMISSION; REVIEW;

6-MERCAPTOPURINE; ADRENAL CORTEX HORMONES; BUDESONIDE; CHILD; CHILD NUTRITION PHYSIOLOGY; CROHN DISEASE; DIET; GROWTH DISORDERS; HUMANS;

EID: 0036314679     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.1.1     Document Type: Review

References (39)

1. Prospective survey of childhood inflammatory bowel disease in the British Isles
2. Crohn's disease in children 10 years old and younger: Comparison with ulcerative colitis
3. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease
4. Growth in Crohn's disease
5. Growth and development in chronic inflammatory bowel disease
6. Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution
7. Linear growth retardation in experimental colitis is induced through a decrease in insulin-like growth factor-I which is independent of malnutrition
8. Growth failure and intestinal inflammation
9. Board of Directors Guidelines for the use of enteral nutrition in the adult patient
10. Elemental diet as primary treatment of acute Crohn's disease: A controlled trial
11. Remission induced by an elemental diet in small bowel Crohn's disease
12. Enteral feeding as sole treatment for Crohn's disease: Controlled trial of whole protein versus amino acid based feed and a case study of dietary challenge
13. Double-blind controlled trial of elemental and polymeric diets as primary therapy in active Crohn's disease
14. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: Elemental and polymeric diet
15. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease
16. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children
17. Elemental diet versus prednisolone as initial therapy in Crohn's disease: Early and long-term results
18. Semi-elemental diet vs. prednisolone in paediatric Crohn's disease
19. Dietary intake and nutritional treatment in childhood Crohn's disease
20. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children
21. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease
22. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomised clinical trials
23. Defined formula diets versus steroids in the treatment of active Crohn's disease. A meta-analysis
24. Therapy of Crohn's disease in childhood
25. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease
26. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by specific oral polymeric diet in paediatric Crohn's disease
27. Growth suppression by corticosteroid therapy
28. Clinical, biological and endoscopic picture of attacks of Crohn's disease; evolution on prednisolone
29. A comparison of budesonide with prednisolone for active Crohn's disease
30. Controlled ileal release budesonide in paediatric Crohn's disease: Efficacy and effect on growth
31. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease
32. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
33. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
34. TNF-α antagonists for the treatment of Crohn's disease
35. A short-term study of chimeric monoclonal antibody, cA2, to tumour necrosis factor alpha for Crohn's disease
36. Retreatment with anti-TNF-α chimeric antibody (cA2) effectively maintains cA2-induced remission in Crohn's disease
37. Use of infliximab in pediatric patients with inflammatory bowel disease
38. Use of infliximab in the treatment of Crohn's disease in children and adolescents
39. The mouse/human chimeric monoclonal antibody cA2 neutralises TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo